Application Information

This drug has been submitted to the FDA under the reference 078941/001.

Names and composition

"ENTACAPONE" is the commercial name of a drug composed of ENTACAPONE.
It belongs to the class COMT inhibitors and is used in Parkinson's disease, parkinsonism (Central Nervous System)

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
078941/001 ENTACAPONE ENTACAPONE TABLET/ORAL 200MG
090690/001 ENTACAPONE ENTACAPONE TABLET/ORAL 200MG
202394/001 ENTACAPONE ENTACAPONE TABLET/ORAL 200MG
203437/001 ENTACAPONE ENTACAPONE TABLET/ORAL 200MG
207210/001 ENTACAPONE ENTACAPONE TABLET/ORAL 200MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
020796/001 COMTAN ENTACAPONE TABLET/ORAL 200MG
078941/001 ENTACAPONE ENTACAPONE TABLET/ORAL 200MG
090690/001 ENTACAPONE ENTACAPONE TABLET/ORAL 200MG
202394/001 ENTACAPONE ENTACAPONE TABLET/ORAL 200MG
203437/001 ENTACAPONE ENTACAPONE TABLET/ORAL 200MG
207210/001 ENTACAPONE ENTACAPONE TABLET/ORAL 200MG

Manufacturers

Manufacturer name
Orion Pharma (UK) Ltd

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved